![Lorcan Murphy](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Lorcan Murphy
Directeur/Bestuurslid bij 4BIO Ventures Management Ltd.
Oorsprong van het eerstegraads netwerk van Lorcan Murphy
Entiteit | Type entiteit | Industrie | |
---|---|---|---|
4BIO Ventures Management Ltd.
![]() 4BIO Ventures Management Ltd. Investment ManagersFinance 4BIO Ventures Management Ltd (4bio Capital Partners) is an independent venture capital firm founded in 2014 by Andrey Kozlov. The firm headquartered in London, United Kingdom.
17
| Holding Company | Investment Managers | 17 |
ACOLIN Fund Services AG
![]() ACOLIN Fund Services AG Investment ManagersFinance ACOLIN Fund Services AG engages in the distribution of domestic and foreign collective investment schemes. It also offers financial products and consulting services. The company was founded on January 31, 2018 and is headquartered in Zurich, Switzerland.
7
| Private Company | Investment Managers | 7 |
Trinity College London
1
| College/University | Other Consumer Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Lorcan Murphy via zijn persoonlijke netwerk
Onderneming | Sector | Gelieerde personen | Hoofdpost |
---|---|---|---|
The Salk Institute for Biological Studies | College/University | Director/Board Member | |
PricewaterhouseCoopers LLP
![]() PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Miscellaneous Commercial Services | Private Equity Analyst | |
University of Oxford | College/University | Graduate Degree Graduate Degree Undergraduate Degree Graduate Degree | |
Enso Ventures Ltd.
![]() Enso Ventures Ltd. Investment ManagersFinance Enso Ventures Ltd (Enso Ventures) is an independent venture capital firm founded in 2010 by Nikolay Danilov. The firm is headquartered in London, United Kingdom. | Investment Managers | Corporate Officer/Principal Private Equity Investor Director of Finance/CFO | |
Redpin Therapeutics, Inc.
![]() Redpin Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Redpin Therapeutics, Inc. operates as a biotechnological platform which enables targeted regulation of neuronal activity in brain to achieve treatment and control of CNS circuit and other disorders. The company was founded by Elma S. Hawkins, Jeffrey Friedman, Scott Sternson Michael Kaplitt, Sarah Stanley and Jonathan Dordick in 2017 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Chairman | |
Code Biotherapeutics, Inc.
![]() Code Biotherapeutics, Inc. BiotechnologyHealth Technology Code Biotherapeutics, Inc. is a next-generation gene therapy company based in Greater Philadelphia. The American company is focused on developing targeted non-viral gene therapies to treat serious and life-threatening genetic diseases. The company uses a novel multivalent synthetic DNA delivery platform called 3DNA, which overcomes many of the challenges associated with viral-based gene therapies. Code Biotherapeutics is advancing an internal pipeline focused on select rare disease programs and establishing partnerships to take forward programs in both rare and prevalent diseases. Code Biotherapeutics is supported by top-tier investors that believe in their work to drive discovery programs forward as they aim to deliver on the promise of their proprietary synthetic DNA-based, non-viral genetic medicines delivery platform. The company was founded by Brian P. McVeigh, who has been the CEO since incorporation. | Biotechnology | Director/Board Member Chief Executive Officer | |
Locki Therapeutics Ltd.
![]() Locki Therapeutics Ltd. BiotechnologyHealth Technology Locki Therapeutics Ltd. is a British preclinical stage biotechnology company founded in 2019. The company is based in London, UK. Locki Therapeutics is developing a new class of drugs that enhance the function of beneficial proteins. The company has designed its proprietary encompass™ platform to create enhancement-targeting chimeric (entac™) medicines. These entacs harness the ability of dubs to regulate proteins, expanding the universe of treatable diseases. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Sovereign Capital Partners LLP
![]() Sovereign Capital Partners LLP Investment ManagersFinance Sovereign Capital Partners LLP (Sovereign Capital Partners) is an hprivate equity firm founded in 1988. The firm is headquartered in London, United Kingdom. | Investment Managers | Private Equity Investor Private Equity Investor | |
Moscow State University Lomonosov | College/University | Undergraduate Degree | |
Charterhouse School | College/University | Undergraduate Degree | |
University of Surrey | College/University | Graduate Degree | |
Guildford College | College/University | Graduate Degree | |
Detego Ltd.
![]() Detego Ltd. Packaged SoftwareTechnology Services Detego Ltd. develops and distributes innovative software products for the fashion retail industry. Its products include Detego Suite, Detego InWarehousem Detego InStore, Detego InChannels, and Detego InReports. The company was founded in 2011 and is headquartered in London, the United Kingdom. | Packaged Software | Director of Finance/CFO | |
UltraSoC Technologies Ltd.
![]() UltraSoC Technologies Ltd. Packaged SoftwareTechnology Services UltraSoC Technologies Ltd. engages in the development of debugging technology for the embedded electronic systems. It offers semiconductor IP for on-chip analytics, performance optimization, and hardware-based security. The company was founded by Stephen Karl Heeks, Andrew Brian Thomas Hopkins, and Klaus Dieter McDonald-Maier in 2006 and is headquartered in Cambridge, the United Kingdom. | Packaged Software | Director/Board Member | |
Cancer Research Technology Ltd.
![]() Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chief Tech/Sci/R&D Officer | |
RetroSense Therapeutics LLC
![]() RetroSense Therapeutics LLC Medical SpecialtiesHealth Technology RetroSense Therapeutics LLC provides biotechnology services. It offers gene therapies to restore vision in patients suffering from blindness due to retinitis pigmentosa and advanced dry age-related macular degeneration. The company was founded by Sean Ainsworth in 2009 and is headquartered in Ann Arbor, MI. | Medical Specialties | Director/Board Member | |
Ray Therapeutics, Inc.
![]() Ray Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Ray Therapeutics, Inc. is an American company that is developing a lead candidate, RTX-015, to treat retinitis pigmentosa, a degenerative retinal disease. Ray Therapeutics is based in an undisclosed location. The company's mission is to restore vision for people with retinal degeneration using optogenetics gene therapies. Ray Therapeutics is pursuing multiple drug development programs for a range of degenerative retinal diseases, focusing on preserving and restoring vision in patients using the ground-breaking science of optogenetics. The company was founded by Paul Bresge and Sean Ainsworth, with Paul Bresge serving as CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member | |
Lomonosov Moscow State University Business School | College/University | Doctorate Degree | |
Araris Biotech AG
![]() Araris Biotech AG Miscellaneous Commercial ServicesCommercial Services Araris Biotech AG engages in the development and research of an antibody-drug conjugate (ADC) linker technology. It focuses on the production of ADCs. Its linker platform enables the attachment of payload to off the shelf antibodies without the need of antibody engineering. The company was founded by Philipp Spycher, Isabella Attinger-Toller, and Dragan Grabulovski and is headquartered in Z?rich, Switzerland. | Miscellaneous Commercial Services | Director/Board Member | |
University of Bridgeport | College/University | Undergraduate Degree | |
University of California San Diego | College/University | Masters Business Admin | |
Cornell University
![]() Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Doctorate Degree | |
LOGICBIO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
LaSalle University | College/University | Undergraduate Degree | |
BNP Paribas S.B. Ré. SA
![]() BNP Paribas S.B. Ré. SA Life/Health InsuranceFinance Part of BNP Paribas SA, BNP Paribas S.B. Ré. The company is based in Luxembourg, Luxembourg. SA provides reinsurance services. | Life/Health Insurance | Corporate Officer/Principal | |
Business Growth Fund Ltd
![]() Business Growth Fund Ltd Investment ManagersFinance Business Growth Fund Ltd (BGF) is private equity firm founded in 2011 by Stephen Welton. The firm is headquartered in the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
Victoria University of Wellington | College/University | Undergraduate Degree | |
Disruptive Capital Finance LLP
![]() Disruptive Capital Finance LLP Investment ManagersFinance Disruptive Capital Finance LLP (Disruptive Capital) is a private equity firm founded in 2006 by Cédriane Marie de Boucaud Truell, Edmund George Truell and Roger Le Tissiermr. The firm is headquartered in London. | Investment Managers | Director of Finance/CFO | |
University of Bristol | College/University | Undergraduate Degree | |
SparingVision SAS
![]() SparingVision SAS BiotechnologyHealth Technology SparingVision SAS develops therapeutic approach for treatment of blinding inherited retinal diseases such as retinitis pigmentosa. The company was founded by Jose Alain Sahel, Thierry Leveillard and Florence Allouche Ghrenassia and is headquartered in Paris, France. | Biotechnology | Director/Board Member | |
Lazard
![]() Lazard Investment ManagersFinance Lazard is a private company that provides financial advisory and asset management services. The company is based in New York, NY. The company was founded in 1848 by Alexandre Lazard. The CEO is Kenneth Marc Jacobs. | Investment Managers | Private Equity Analyst | |
Intertrust Group BV
![]() Intertrust Group BV Financial ConglomeratesFinance Intertrust Group BV engages in the provision of administrative services to clients that operate and invest in the international business environment. It offers corporate client; private equity and debt fund; real estate; hedge fund; capital markets; performance and reward management; private wealth; regulatory and compliance; China desk; Brexit; and consultancy services. The company was founded in 1952 is headquartered in Amsterdam, the Netherlands. | Financial Conglomerates | Chief Operating Officer | |
INTERTRUST N.V. | Miscellaneous Commercial Services | Chief Operating Officer | |
Villanova University | College/University | Masters Business Admin | |
IP Group Plc /Venture Capital/
![]() IP Group Plc /Venture Capital/ Investment ManagersFinance IP Group Plc /Venture Capital/ (IP Group) is a venture capital subsidiary of IP Group Plc founded in 2001. The firm is headquartered in London, United Kingdom. | Investment Managers | Consultant / Advisor | |
Scineuro Pharmaceuticals
![]() Scineuro Pharmaceuticals BiotechnologyHealth Technology SciNeuro Pharmaceuticals is a Chinese clinical-stage biotechnology company that focuses on developing therapies for neurodegenerative diseases such as Alzheimer's and Parkinson's disease. SciNeuro Pharmaceuticals is based in Shanghai, China, and has corporate and R&D facilities located in both Shanghai and Beijing. SciNeuro has built a portfolio of pipeline programs that address three key disease-driving mechanisms of neurodegeneration. The company is committed to delivering medicines that can make a difference in the lives of patients around the world. The company is an innovation-driven, neuroscience-focused biopharmaceutical company that uses in-house discovery and development to create innovative therapeutics for neurodegenerative and other CNS diseases. The company was founded in 2020 by Min Li, who has been the CEO since then. | Biotechnology | Consultant / Advisor | |
UPMC Enterprises
![]() UPMC Enterprises Investment ManagersFinance UPMC Enterprises (UPMC Enterprises) is a venture capital subsidiary of University of Pittsburgh Medical Center founded in 2014. The firm is headquartered in Pittsburgh, Pennsylvania. | Investment Managers | Consultant / Advisor | |
GSK PLC | Pharmaceuticals: Major | Chief Investment Officer | |
Genisphere LLC
![]() Genisphere LLC Electronic Equipment/InstrumentsElectronic Technology Genisphere LLC manufactures kits and reagents used for the ultra-sensitive detection of nucleic acids and proteins. Its solutions are primarily based on its proprietary whole transcriptome RNA Amplification processes, miRNA labeling methodologies, and 3DNA Dendrimer Nanotechnology. The firm's combined technologies permit the interrogation and ultra-sensitive detection of a wide range of biomolecules on a variety of detection platforms, including microarrays, flow and bead based assays, ELISAs, lateral flow assays and RNA sequencing. The company was founded in 1997 and is headquartered in Hatfield, PA. | Electronic Equipment/Instruments | Director/Board Member | |
Licensing Executives Society | Corporate Officer/Principal |
Statistieken
Internationaal
Verenigde Staten | 17 |
Verenigd Koninkrijk | 16 |
Nieuw-Zeeland | 3 |
Rusland | 3 |
Nederland | 3 |
Sectoraal
Consumer Services | 15 |
Finance | 10 |
Health Technology | 10 |
Commercial Services | 6 |
Electronic Technology | 3 |
Operationeel
Director/Board Member | 50 |
Corporate Officer/Principal | 15 |
Private Equity Investor | 13 |
Undergraduate Degree | 12 |
Chairman | 12 |
Sterkste connecties
Insiders | |
---|---|
Michael Covell | 16 |
Brian McVeigh | 15 |
Andrey Kozlov | 12 |
Kieran Mudryy | 10 |
Philippe Fauchet | 9 |
Dmitry Kuzmin | 9 |
Clive Stanway | 8 |
Matthew Appleton | 7 |
Alex Hay | 7 |
Leszek Lisowski | 6 |
Owen Smith | 6 |
James Dargan | 5 |
Edward McGill | 5 |
Theo Splinter | 4 |
Leigh Edgar | 3 |
- Beurs
- Insiders
- Lorcan Murphy
- Bedrijfsconnecties